Toshiaki Ohara

12PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyOral implantology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 27, 2026
SPRED2 Negatively Regulates CD8+ T Cell-Mediated Antitumor Immunity in Breast Cancer.

|Apr 14, 2026
CXCR2-Dependent Infiltration of Tumor-Associated Neutrophils Is Linked to Enhanced CD8+ T Cell Effector Function and Reduced Lung Metastasis in 4T1 Breast Cancer.

Tiantian Li, Teizo Yoshimura, Miao Tian

|Jun 19, 2024
SPRED2 Is a Novel Regulator of Autophagy in Hepatocellular Carcinoma Cells and Normal Hepatocytes.

Tianyi Wang, Tong Gao, Masayoshi Fujisawa

|May 31, 2024
The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer.

Hnin-Wint-Wint Swe, Masayoshi Fujisawa, Toshiaki Ohara

|Apr 19, 2024
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody.

Teruki Kobayashi, Kazuhiro Noma, Seitaro Nishimura

|Nov 24, 2023
Novel Iron Chelators, Super-Polyphenols, Show Antimicrobial Effects against Cariogenic Streptococcus mutans.

Yuki Shinoda-Ito, Kazuhiro Omori, Takashi Ito

Pageof 2

Frequent Collaborators

6 joint publications

Teizo Yoshimura

4 joint publications

Hiroshi Tazawa

4 joint publications

Toshiyoshi Fujiwara

4 joint publications

Akihiro Matsukawa